Data showed that at least 12 stocks, which were traded below Rs 1 in April 2013, have surged up to 208 times in the last 10 years, with Shukra Pharmaceuticals leading the pack with a rally of 20,744 per cent.
Net Sales at Rs 0.01 crore in December 2022 down 92.62% from Rs. 0.07 crore in December 2021.
Quarterly Net Profit at Rs. 0.00 crore in December 2022 down 60% ...
Ambar Protein Industries and IKAB Securities & Investment also rallied 2,636 per cent and 1,847 per cent respectively during the period. Gensol Engineering also rose 1,637 per cent during the same period, the data suggest.
A general trend is that most of the multibaggers in the list are from smallcap space, where there is more room for them to grow. Among better-known names that have surged multifold in the period are NDTV, DB Realty, Ugar Sugar Works, Triveni Glass and Gujarat Mineral Development Corporation.
Penny stocks have no defined theoretical definition. However, stocks in single digits or below Rs 10 are bracketed in this club. In this study, companies with a market cap of less than Rs 1,000 crore at the end of 2021 have been considered.
Domestic markets continued to be dominated by bears on Tuesday, extending their losses even though Wall Street equity indices staged a smart recovery on Monday.
These 25 stocks have rallied between 100-160 per cent since January 1, 2022, suggests data available with ACE Equity. Ten other names have rallied more than 90 per cent during the period under review. This is at a time when the recent selloff has shaved off gains for BSE Sensex and NSE Nifty, with both turning flat on a year-to-date (YTD) basis.